Loading...

Alzheimer's Association International Conference 2026

July 12-15, 2026 | London, United Kingdom, and Online

Topics

Select Topic

Showing 4,068 results.

Thumbnail for Integrated Blood Transcriptomic And Proteomic Analyses Identify Biomarkers Of Lecanemab Response In Early Alzheimer’S Disease

13253

Integrated Blood Transcriptomic And Proteomic Analyses Identify Biomarkers Of Lecanemab Response In Early Alzheimer’S Disease

Aidi Shan

Poster Presenter: Aidi Shan

Thumbnail for Cognitive Function And Plasma Biomarkers Dynamics In Alzheimer's Disease During Lecanemab Treatment: A Real-world Clinical Study

13255

Cognitive Function And Plasma Biomarkers Dynamics In Alzheimer's Disease During Lecanemab Treatment: A Real-world Clinical Study

Lai Yu-Jie

Poster Presenter: Lai Yu-Jie

Thumbnail for Determinants And Capacity Gaps For Harmonizing Memory Clinic Practice: Evidence From The REMEMVER Initiative

13256

Determinants And Capacity Gaps For Harmonizing Memory Clinic Practice: Evidence From The REMEMVER Initiative

Ignacio López - Barrenechea, Teresa Rubilar-Ruiz, María José Alarcón Plasser, Paulina Vergara, Natalia Pozo Castro, Teresita de Jesús Ramos Franco, Claudia Reyes, Teresa Castillo, Lorena Mor...

Memory Clinic, Neurology Department, Hospital Clínico Dr. Guillermo Grant Benavente, Concepción, Chile, Hospital San Borja Arriarán, Santiago, Chile, Unidad de Memoria Neurology, Hospital del Salvador, Santiago...

Poster Presenter: Ignacio López - Barrenechea

Thumbnail for Neurobiological Bases Of Motor And Cognitive Deficits In The Context Of Early Alzheimer Detection

13257

Neurobiological Bases Of Motor And Cognitive Deficits In The Context Of Early Alzheimer Detection

Mauricio Alba Gonzalez, Eyitomilayo Babatope, Mireya Saraí García Vazquez

Instituto Politécnico Nacional - CITEDI, Instituto Politécnico Nacional - ENMH

Poster Presenter: Mauricio Alba Gonzalez

Thumbnail for Reducing Access Barriers To Care In Alzheimer’S Disease And Related Dementias: Insights From A Parkinson’s Disease Model

13260

Reducing Access Barriers To Care In Alzheimer’S Disease And Related Dementias: Insights From A Parkinson’s Disease Model

Sanaea Bhagwagar, John Dempsey, Simone Seward, Justin Meyer, Tinatin Chabrashvili

State University of New York Upstate Medical University

Poster Presenter: Sanaea Bhagwagar

Thumbnail for Amyloid-related Imaging Abnormalities And Associated Factors In Lecanemab-treated Patients With Alzheimer’S Disease: The JOY-ALZ Study

13262

Amyloid-related Imaging Abnormalities And Associated Factors In Lecanemab-treated Patients With Alzheimer’S Disease: The JOY-ALZ Study

Seong Hye Choi

Poster Presenter: Seong Hye Choi

Thumbnail for Retinal Microvascular Changes During Donanemab Therapy In Early Alzheimer’S Disease: A 6-month Longitudinal Study.

13264

Retinal Microvascular Changes During Donanemab Therapy In Early Alzheimer’S Disease: A 6-month Longitudinal Study.

Suqing Hu

Poster Presenter: Suqing Hu

Thumbnail for Emerging Digital Biomarkers For Early Detection Of Alzheimer’s Disease At The Primary Care Level

13265

Emerging Digital Biomarkers For Early Detection Of Alzheimer’s Disease At The Primary Care Level

Mauricio Alba Gonzalez, Eyitomilayo Babatope, Mireya Saraí García Vazquez

Instituto Politécnico Nacional- ENMH, Instituto Politécnico Nacional - CITEDI

Poster Presenter: Mauricio Alba Gonzalez

Thumbnail for A-beta Oligomer Lowering Treatment With PRI-002 Does Not Cause Aria In Ongoing Phase 2 Trial

13266

A-beta Oligomer Lowering Treatment With PRI-002 Does Not Cause Aria In Ongoing Phase 2 Trial

Oliver Peters

Poster Presenter: Oliver Peters

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.